Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset - HMS LINCS Database

Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>

Cell	Small Molecule	Small Mol Concentration (uM)	Primary Target	Pathway	Mean Normalized Growth Rate Inhibition Value	Increased Fraction Dead
T47D	Ipatasertib	0.31623	AKT	PI3K/mTOR	0.3286	0.01648
T47D	Ipatasertib	1.0	AKT	PI3K/mTOR	0.1884	0.01828
T47D	Ipatasertib	3.1623	AKT	PI3K/mTOR	0.1331	0.02540
T47D	Ipatasertib	10.0	AKT	PI3K/mTOR	0.1402	0.02929
T47D	Alpelisib	0.001	PI3Ka	PI3K/mTOR	1.0781	0.00072
T47D	Alpelisib	0.0031623	PI3Ka	PI3K/mTOR	1.0415	0.00157
T47D	Alpelisib	0.01	PI3Ka	PI3K/mTOR	0.8915	0.00055
T47D	Alpelisib	0.031623	PI3Ka	PI3K/mTOR	0.7429	0.00918
T47D	Alpelisib	0.1	PI3Ka	PI3K/mTOR	0.5767	0.00912
T47D	Alpelisib	0.31623	PI3Ka	PI3K/mTOR	0.3518	0.01207
T47D	Alpelisib	1.0	PI3Ka	PI3K/mTOR	0.1904	0.02302
T47D	Alpelisib	3.1623	PI3Ka	PI3K/mTOR	0.0422	0.03677
T47D	Alpelisib	10.0	PI3Ka	PI3K/mTOR	-0.0332	0.06965
T47D	Taselisib	0.001	PI3Ka, g, d	PI3K/mTOR	0.6727	0.00360
T47D	Taselisib	0.0031623	PI3Ka, g, d	PI3K/mTOR	0.3265	0.02050
T47D	Taselisib	0.01	PI3Ka, g, d	PI3K/mTOR	0.1037	0.03585
T47D	Taselisib	0.031623	PI3Ka, g, d	PI3K/mTOR	0.0519	0.04296
T47D	Taselisib	0.1	PI3Ka, g, d	PI3K/mTOR	0.0051	0.04903
T47D	Taselisib	0.31623	PI3Ka, g, d	PI3K/mTOR	-0.0046	0.06924
T47D	Taselisib	1.0	PI3Ka, g, d	PI3K/mTOR	0.0382	0.06275
T47D	Taselisib	3.1623	PI3Ka, g, d	PI3K/mTOR	0.0034	0.07274
T47D	Taselisib	10.0	PI3Ka, g, d	PI3K/mTOR	-0.1047	0.13876
T47D	TGX221	0.001	PI3Kb	PI3K/mTOR	1.0725	0.00126
T47D	TGX221	0.0031623	PI3Kb	PI3K/mTOR	1.0733	-0.00116
T47D	TGX221	0.01	PI3Kb	PI3K/mTOR	1.0730	0.00055